Split-thickness skin graft (STSG) continues to be the preferred means of external auditory canal (EAC) reconstruction. We thus sought to describe our experience using skin from the posterior aspect of the auricle (SPAA) as a donor site in EAC reconstruction. Grafts were, on average, 5 3 10 mm in size and obtained with a No. 10 blade after tumescence injection. The cases of 39 patients who underwent 41 procedures were retrospectively reviewed. Of the 38 patients with both 3-and 6-month follow-ups, no postoperative stenosis or bony exposure occurred. STSG from the SPAA can be a good option in EAC reconstruction. Total EAC/tympanic membrane coverage can be obtained with STSG from the SPAA.
xternal auditory canal (EAC) reconstruction for coverage of the canal is commonly required when there is inadequate residual healthy skin. While up to 50% of EAC skin can be lost and still heal successfully without grafting, greater defects require grafting to prevent restenosis. 1 One of the common complications of EAC reconstruction is restenosis of the EAC. 2 Reconstruction can be performed with split-thickness skin grafts (STSGs), fullthickness grafts, preauricular flaps, or postauricular flaps. 3 If STSG is desired for reconstruction, there are multiple possible donor sites, most commonly the medial arm or anterior thigh. We herein present our outcomes of patients who had STSG obtained from the skin from the posterior aspect of the auricle (SPAA).
Materials and Methods
After approval by our institutional review board, we performed a retrospective review of patients who had a STSG obtained from the SPAA by the senior surgeon from 2009 to 2016. A total of 39 patients who underwent 42 procedures were included.
Injection is performed with 1% lidocaine with 1:100,000 epinephrine into the SPAA in the subcutaneous plane. Once adequate tumescence is achieved, a No. 10 blade is used to harvest the STSG in a sawing fashion ( Figure 1 ). We aim for grafts to be thinner than that of the thickness of the blade (0.36 mm). On average, the grafts are approximately 5 3 10 mm, and 8 grafts are obtained per patient ( Figure 2) . In cases where a postauricular incision was made, we leave 5 mm between the incision and the donor site. The grafts are prepared off the field and placed on 0.005-inch Silastic coated with a thin layer of bacitracin. The STSG is then laid down in the EAC with the Silastic. Once positioned, the Silastic was removed. Extreme caution is taken to ensure that the entire skin defect is covered and that the grafts are laid down in a flat configuration ( Figure 1 ). If grafts are placed along the tympanic membrane, 0.51-mm-thick Silastic sheets are used to keep the graft in place and the anterior sulcus angle sharp. If a cartilaginous canal meatoplasty was performed, the meatus is injected with triamcinolone acetonide (40 mg/mL) in 4 quadrants to prevent stenosis. Otherwise, otowicks are placed in the EAC as a stent to keep the grafts compressed against the canal. Tegaderm is placed over the donor site. All patients were seen postoperatively after 1 week for packing removal and at approximately 4 to 6 weeks. Thirty-eight patients additionally had 3-and 6-month follow-ups.
Results
The average age of the patients was 35.4 years (range, 2-80 years). The average time of last follow-up was 54 weeks (range, 4-282 weeks). Indications for the procedure included EAC stenosis from chronic EAC infection/granulation in 26 patients, congenital EAC stenosis in 9, tumor in 5, and bony exposure from previous ear surgery in 1 ( Table 1) .
Findings at the first postoperative visit are shown in Table 2 . Patients with EAC granulation were managed with silver nitrate application, triamcinolone ointment application, or both. All patients with EAC granulation demonstrated resolution at the 4-week follow-up. Patients with evidence of acute edema were managed with triamcinolone acetonide injections in 4 quadrants of the EAC. Two patients required prolonged wicking for 3 weeks. No patient developed prolonged postoperative EAC stenosis or bony exposure. At the last visit, all patients demonstrated at least 90% to 95% canal opening.
With regard to donor site complications, 1 patient developed a 5-mm skin bridge between the donor site and the postauricular incision. This was lysed, and a Steri-Strip was applied to prevent reformation. One patient developed donor site bleeding and pain. No patients developed longterm complications of the donor site, and all donor sites appeared well healed on last follow-up. Figure 3 demonstrates the typical donor site appearance at the 6-week postoperative visit.
Discussion
Our experience supports that SPAA is a good source for STSG in patients requiring EAC reconstruction. This appears to be a reasonable alternative to an extremity donor site, which requires the intraoperative preparation of an alternate site and can lead to a more visible scar. STSG reconstruction of the EAC has been evaluated in several case series, most of which have demonstrated low rates of restenosis in small series. 4, 5 While acute postoperative edema/granulation or mucosalization from STSG from SPAA is possible, no patients in our series developed prolonged postoperative EAC stenosis or bony exposure. The STSG used in EAC reconstruction needs to be thin to ensure improved take and to decrease the risk of stenosis, which is why we aim for the grafts to be thinner than the blade. During harvest, the blade edge should remain visible through the skin graft. The use of a fresh blade facilitates obtaining a very thin graft that is sizable. The blade is generally used for 2 to 3 grafts at most before the need to switch to a fresh blade. Tumescence and stretching of the auricle with a finger inside the concha also facilitate harvest of a very thin graft. During harvest, it is beneficial to leave very thin strips of intact skin between the grafts to reduce the likelihood of scar formation and to assist in donor site healing. At no point should fat become visible in harvesting of the graft.
Our series found that the long-term risks of obtaining an STSG from SPAA for EAC reconstruction to be very low, comparable to those reported in other series. This study is not without its limitations. We did not have pre-and postoperative audiometry in several patients, and there was no objective report on the donor site. Longer follow-up can also be beneficial. Prospective evaluation of this technique and comparison of SPAA with alternate donor sites are necessary.
Conclusion
The SPAA is a possible donor site for STSG in EAC reconstruction and may have advantages over STSG from other donor sites.
Author Contributions
Yarah M. Haidar, contributed to concept and design of work, drafting of manuscript, and final manuscript approval; Sartaaj Walia, contributed to concept and design of work, drafting of manuscript, and final manuscript approval; Ronald Sahyouni, contributed to concept and design of work, drafting of manuscript, and final manuscript approval; Yaser Ghavami, contributed to concept and design of work, drafting of manuscript, and final manuscript approval; Harrison W. Lin, contributed to concept and design of work, drafting of manuscript, and final manuscript approval; Hamid R. Djalilian, contributed to concept and design of work, revising manuscript, and final manuscript approval.
Disclosures
Competing interests: None.
Sponsorships: None.
Funding source: None. 
